Stocks and Investing Stocks and Investing
Fri, May 26, 2023

Matthew Biegler Reiterated (ZNTL) at Buy and Held Target at $50 on, May 26th, 2023


Published on 2024-10-28 04:02:54 - WOPRAI, Matthew Biegler
  Print publication without navigation


Matthew Biegler of Oppenheimer, Reiterated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy and Held Target at $50 on, May 26th, 2023.

Matthew has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Bradley Canino of "Stifel" Maintained at Strong Buy and Held Target at $45 on, Tuesday, May 23rd, 2023
  • Biren Amin of "Jefferies" Maintained at Strong Buy with Decreased Target to $70 on, Friday, May 19th, 2023
Contributing Sources